Literature DB >> 19199272

Detection of cytokeratin 19 mRNA and CYFRA 21-1 (cytokeratin 19 fragments) in blood of Tunisian women with breast cancer.

R Marrakchi1, S Ouerhani, S Benammar, K Rouissi, R Bouhaha, K Bougatef, Y Messai, I Khadimallah, K Rahal, A Ben Ammar-Elgaaied.   

Abstract

Cytokeratin 19 (CK19) is an acidic protein of 40 kDa that is part of the cytoskeleton of epithelial cells. It is highly expressed by all epithelial cells and represents a useful indicator of epithelial differentiation. The soluble fragment of CK19 (CYFRA 21-1) can be a useful circulating tumor marker and can be detected in the serum of cancer patients. The development of metastasis in patients with cancer of epithelial origin is due to the migration of tumor cells from the original tumor to distant organs. In order to detect micrometastasis in patients with breast cancer, we evaluated and compared CK19 gene expression using RT-PCR in blood samples collected from 80 healthy women and 80 patients with localized or metastatic breast cancer. The concentration of the soluble CK19 fragment CYFRA 21-1 was measured in serum of all study subjects by radioimmunoassay employing specific monoclonal antibodies. The relationship between the expression of this molecular marker and clinical stage, tumor differentiation and CK19 mRNA transcripts was investigated. We found that CK19 mRNA expression in blood (as a direct index of the presence of circulating tumor cells) was not correlated with CYFRA 21-1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19199272     DOI: 10.1177/172460080802300407

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   3.248


  6 in total

1.  A novel immunoassay for the quantization of CYFRA 21-1 in human serum.

Authors:  An He; Tian-Cai Liu; Zhi-Ning Dong; Zhi-Qi Ren; Jing-Yuan Hou; Ming Li; Ying-Song Wu
Journal:  J Clin Lab Anal       Date:  2013-07       Impact factor: 2.352

2.  Mitochondrial Dysfunction Contributes to Aging-Related Atrial Fibrillation.

Authors:  Chuanbin Liu; Jing Bai; Qing Dan; Xue Yang; Kun Lin; Zihao Fu; Xu Lu; Xiaoye Xie; Jianwei Liu; Li Fan; Yang Li
Journal:  Oxid Med Cell Longev       Date:  2021-04-28       Impact factor: 6.543

3.  mRNA expression of CK19, EGFR and LUNX in patients with lung cancer micrometastasis.

Authors:  Xiansen Zhang; Jing Xie; Changfa Yu; Lixia Yan; Zeshan Yang
Journal:  Exp Ther Med       Date:  2013-11-19       Impact factor: 2.447

4.  Fine-needle aspirate CYFRA 21-1, an innovative new marker for diagnosis of axillary lymph node metastasis in breast cancer patients.

Authors:  Ji Soo Choi; Kyung Hwa Han; Eun-Kyung Kim; Hee Jung Moon; Jung Hyun Yoon; Min Jung Kim
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 5.  The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.

Authors:  Saber Imani; Xianqin Zhang; Hossein Hosseinifard; Shangyi Fu; Junjiang Fu
Journal:  Oncotarget       Date:  2017-04-04

Review 6.  Receptor-defined subtypes of breast cancer in indigenous populations in Africa: a systematic review and meta-analysis.

Authors:  Amanda Eng; Valerie McCormack; Isabel dos-Santos-Silva
Journal:  PLoS Med       Date:  2014-09-09       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.